Bladder Squamous Cell Carcinoma
1 competing product in clinical development for Bladder Squamous Cell Carcinoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enfortumab Vedotin + Pembrolizumab | Astellas Pharma | Phase 2 | Recruiting | 42 |